Now that Dr. Clark Gamblin has ran the World Marathon Challenge, Wisconsin's Morning News producer Greg 'Pancake' Hill reconnected with the cancer ...

For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found ...

Vigil is the first cellular immunotherapy to demonstrate longer-term survival benefits in a randomized controlled trial of patients with solid tumors. The results of the company's Phase 2b study have ...